• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead GrowMyMoney Invest Now master your money
Moneycontrol

Home » News » Announcements

Jan 09, 2017, 10.51 AM | Source: Moneycontrol.com

Divis Lab: Update on USFDA inspection of Unit-II at Visakhapatnam

Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the ‘Form 483’ observations of the US-FDA within the time permitted.

Like this story, share it with millions of investors on M3

Divis Lab: Update on USFDA inspection of Unit-II at Visakhapatnam

Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the ‘Form 483’ observations of the US-FDA within the time permitted.

Post Your Comments

Share Cancel

Divis Laboratories Ltd has informed BSE that the company has already filed its detailed response to the ‘Form 483’ observations of the US-FDA within the time permitted.Source : BSE

Read all announcements in Divis Labs

To read the full report click here

Buy, Hold, Sell ? Hear it first on M3
Divis Lab: Update on USFDA inspection of Unit-II at Visakhapatnam

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login